M&RP Recent Publications
Below are links to articles recently published regarding measles and rubella (listed first) as well as for articles of interest for other immunization (listed further below.)
Bibliography of citations on Measles and Rubella, May -June 2024
-
Accelerating Global Measles and Rubella Eradication-Saving Millions of Lives, Preventing Disability, and Averting the Next Pandemic.
Durrheim DN, Andrus JK, Tabassum S, Githanga D, Kojouharova M, Talab N.
Vaccines (Basel). 2024 Jun 20;12(6):699.
doi: 10.3390/vaccines12060699.PMID: 38932428
-
Addressing the Dangerous Consequences of the Resurgence of Measles and Rubella: The Critical Need for a Global Target.
Andrus JK.
Vaccines (Basel). 2024 Jun 20;12(6):698.
doi: 10.3390/vaccines12060698.PMID: 38932427
-
Breakthrough Measles among Vaccinated Adults Born during the Post-Soviet Transition Period in Mongolia.
Hagan JE, Crooke SN, Gunregjav N, Sowers SB, Mercader S, Hickman CJ, Mulders MN, Pastore R, Takashima Y, Durrheim DN, Goodson JL, Rota PA.
Vaccines (Basel). 2024 Jun 20;12(6):695.
doi: 10.3390/vaccines12060695.PMID: 38932425
-
Progress and Challenges in Measles and Rubella Elimination in the WHO European Region.
Muscat M, Ben Mamou M, Reynen-de Kat C, Jankovic D, Hagan J, Singh S, Datta SS.
Vaccines (Basel). 2024 Jun 20;12(6):696.
doi: 10.3390/vaccines12060696.PMID: 38932424
-
A World without Measles and Rubella: Addressing the Challenge of Vaccine Hesitancy.
Higgins DM, O’Leary ST.
Vaccines (Basel). 2024 Jun 20;12(6):694.
doi: 10.3390/vaccines12060694.PMID: 38932423
-
Evolution and Contribution of a Global Partnership against Measles and Rubella, 2001-2023.
Strebel P, Grabowsky M, Hoekstra E, Gay A, Cochi S.
Vaccines (Basel). 2024 Jun 20;12(6):693.
doi: 10.3390/vaccines12060693.PMID: 38932422
-
The Case for Assessing the Drivers of Measles Vaccine Uptake.
Kaufman J, Rak A, Vasiliadis S, Brar N, Atif E, White J, Danchin M, Durrheim DN.
Vaccines (Basel). 2024 Jun 20;12(6):692.
doi: 10.3390/vaccines12060692.PMID: 38932421
-
Sustaining the Elimination of Measles, Rubella and Congenital Rubella Syndrome in the Americas, 2019-2023: From Challenges to Opportunities.
Rey-Benito G, Pastor D, Whittembury A, Durón R, Pacis-Tirso C, Bravo-Alcántara P, Ortiz C, Andrus J.
Vaccines (Basel). 2024 Jun 20;12(6):690.
doi: 10.3390/vaccines12060690.PMID: 38932419
-
Evaluating Scope and Bias of Population-Level Measles Serosurveys: A Systematized Review and Bias Assessment.
Sbarra AN, Cutts FT, Fu H, Poudyal I, Rhoda DA, Mosser JF, Jit M.
Vaccines (Basel). 2024 May 28;12(6):585.
doi: 10.3390/vaccines12060585.PMID: 38932314
-
Possible Changes and Trends in Non-COVID-19 Vaccine-Prescribing Patterns before and during COVID-19 Pandemic.
van Rooyen S, Lubbe M, Kotze I, Motaze NV.
Vaccines (Basel). 2024 May 27;12(6):582.
doi: 10.3390/vaccines12060582.PMID: 38932311
-
Modeling the Cost of Vaccinating a Measles Zero-Dose Child in Zambia Using Three Vaccination Strategies.
Mak J, Patenaude BN, Mutembo S, Pilewskie ME, Winter AK, Moss WJ, Carcelen AC.
Am J Trop Med Hyg. 2024 May 21:tpmd230412.
doi: 10.4269/ajtmh.23-0412. Online ahead of print.PMID: 38772386
-
Who is missed in a community-based survey: Assessment and implications of biases due to incomplete sampling frame in a community-based serosurvey, Choma and Ndola Districts, Zambia, 2022.
Kostandova N, Mutembo S, Prosperi C, Mwansa FD, Nakazwe C, Namukoko H, Nachinga B, Chongwe G, Chilumba I, Matakala KH, Musukwa G, Hamahuwa M, Mufwambi W, Matoba J, Situtu K, Mutale I, Kong AC, Simulundu E, Ndubani P, Hasan AZ, Truelove SA, Winter AK, Carcelen AC, Lau B, Moss WJ, Wesolowski A.
PLOS Glob Public Health. 2024 Apr 29;4(4):e0003072.
doi: 10.1371/journal.pgph.0003072. eCollection 2024.PMID: 38683820
-
Measles outbreak investigation in Berhet District, North Shewa, Ethiopia.
Shimelis Y, Asrat A, Tadege T, Feleke SF.
Front Public Health. 2024 May 2;12:1330205.
doi: 10.3389/fpubh.2024.1330205. eCollection 2024.PMID: 38756880
-
Determinants of second-dose measles vaccination dropout in Ethiopia: A community-based matched case-control study.
Adugna B, Tola A, Fite MB, Motuma A
.Heliyon. 2024 May 4;10(9):e30764.
doi: 10.1016/j.heliyon.2024.e30764. eCollection 2024 May 15.PMID: 38756559
-
Measles in the Democratic Republic of the Congo needs urgent attention.
Musa KM, Oduoye MO, Qazi MS, Zulfiqar K.
Ther Adv Infect Dis. 2024 May 14;11:20499361241252534.
doi: 10.1177/20499361241252534. eCollection 2024 Jan-Dec.PMID: 38751757
-
Coverage and determinants of second-dose measles vaccination among under-five children in East Africa countries: a systematic review and meta-analysis.
Alemu TG, Tamir TT, Workneh BS, Mekonen EG, Ali MS, Zegeye AF, Wassie M, Kassie AT, Tekeba B, Gonete AT.
Front Public Health. 2024 May 1;12:1359572.
doi: 10.3389/fpubh.2024.1359572. eCollection 2024.PMID: 38751581
-
Measles second dose vaccine uptake and its associated factors among children aged 24-35 months in Northwest Ethiopia, 2022.
Taffie W, Temesgen H, Ashebir W, Mekonen H.
Sci Rep. 2024 May 14;14(1):11059.
doi: 10.1038/s41598-024-61048-9.PMID: 38744908
-
Multiplex Bead Assay for the Serological Surveillance of Measles and Rubella.
Coughlin MM, Smits G, Matson Z, van Binnendijk R, Bankamp B.
Methods Mol Biol. 2024;2808:225-246.
doi: 10.1007/978-1-0716-3870-5_17.PMID: 38743374
-
Setup of Aerosol Delivery System to Prevent Measles Virus Infection in Nonhuman Primate Model.
Reynard O, Montharu J, Iampietro M, Gonzalez C, Le Guellec S, Horvat B, Vecellio L.
Methods Mol Biol. 2024;2808:167-175.
doi: 10.1007/978-1-0716-3870-5_13.PMID: 38743370
-
Dynamics of measles immunity from birth and following vaccination.
Wang W, O’Driscoll M, Wang Q, Zhao S, Salje H, Yu H.
Nat Microbiol. 2024 May 13.
doi: 10.1038/s41564-024-01694-x. Online ahead of print.PMID: 38740931
-
Implications of suboptimal measles immunity in UK health-care workers.
Ho A, Galgut O, Faustini S, Peters N, Shields A, Klenerman P, Hopkins S, Hall V, Dunachie N
Lancet. 2024 Jun 26:S0140-6736(24)01011-0.
doi: 10.1016/S0140-6736(24)01011-0.
-
"If the nurse tells me this is a good thing, I trust her completely" - Exploring health system enablers of MMR vaccine uptake in the Finnish Somali community: A mixed method study.
Hussein I, Mohamud H, Hussein A, Luomala O, Kontio M, Edelstein M, Nohynek H.
Vaccine. 2024 Jun 25:S0264-410X(24)00728-X.
doi: 10.1016/j.vaccine.2024.06.054. Online ahead of print.PMID: 38926069
-
Economic evaluation of second measles containing vaccine (MCV) dose: a systematic review of available evidence.
Bawa S, Wondimu A, Postma MJ, Hutubessy R, van Hulst M.
Expert Rev Vaccines. 2024 Jan-Dec;23(1):655-673.
doi: 10.1080/14760584.2024.2367451. Epub 2024 Jun 26.PMID: 38924461
-
The implementation of a new measles vaccine mandate in Germany: A qualitative study in local health departments.
Werdin S, Neufeind J.
PLoS One. 2024 Jun 25;19(6):e0306003.
doi: 10.1371/journal.pone.0306003. eCollection 2024.PMID: 38917137
-
Phase III, open-label, single-arm study of a new MMR vaccine (JVC-001); measles AIK-C, mumps RIT 4385, rubella Takahashi, as a second vaccine dose in healthy Japanese children aged 5-6 years.
Nakayama T, Kawamura A, Sogawa Y, Sakakibara S, Nakatsu T, Kimata M, Oe K.
J Infect Chemother. 2024 Jun 19:S1341-321X(24)00166-1.
doi: 10.1016/j.jiac.2024.06.011. Online ahead of print.PMID: 38906375
-
Maternal antibody level, sex and birth route drive individual measles immunity differences.
[No authors listed]
Nat Microbiol. 2024 Jun 20.
doi: 10.1038/s41564-024-01741-7. Online ahead of print.PMID: 38902375
-
Quantifying the risk of measles importation and spread in the United States in 2024.
Bidari S, Yuan H, Yang W.
medRxiv [Preprint]. 2024 Jun 7:2024.06.06.24308559.
doi: 10.1101/2024.06.06.24308559.PMID: 38883772
-
Relationship between parental acceptance of the COVID-19 vaccine and attitudes towards measles vaccination for children: A cross-sectional study.
Jiang X, Wang J, Li C, Yeoh EK, Guo Z, Lin G, Wei Y, Chong KC.
Vaccine. 2024 Jun 15:S0264-410X(24)00708-4.
doi: 10.1016/j.vaccine.2024.06.035. Online ahead of print.PMID: 38880690
-
Re-examining the measles outbreak in the Philippines: Strengthening the vaccination program through women.
San Juan FG.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2359808.
doi: 10.1080/21645515.2024.2359808. Epub 2024 Jun 11.PMID: 38860705
-
Measles Infection Dose Responses: Insights from Mathematical Modeling.
Anelone AJN, Clapham HE.
Bull Math Biol. 2024 Jun 9;86(7):85.
doi: 10.1007/s11538-024-01305-0.PMID: 38853189
-
Epidemiology of measles in southern Iran: trends, challenges, and vaccination insights.
Hassani Azad M, Dehghani Sargazi L, Salari M, Jahangiri S, Hashemi SM, Asadi SS, Ghaedi Hengami G, Ghazalgoo A, Keivanlou MH, Amini-Salehi E, Asadi Yousefabad SH.
Ann Med Surg (Lond). 2024 Apr 3;86(6):3273-3280.
doi: 10.1097/MS9.0000000000002004. eCollection 2024 Jun.PMID: 38846899
-
Seroepidemiology of measles and rubella among Hong Kong young adults and the humoral responses of an MMR booster among participants with low antibody levels.
Chan JCH, Leung D, Chan SM, Tam IYS, Lam JHY, Chan KW, Zhang K, Chiu TLH, Yeung THM, Chung GMH, Rosa Duque JS, Lau YL.
J Infect Dis. 2024 Jun 5:jiae297.
doi: 10.1093/infdis/jiae297. Online ahead of print.PMID: 38839048
-
Active surveillance of immunization adverse effects: a multicentre, open-label, three-arm randomized uncontrolled trial in Ethiopia.
Assefa DG, Tesefaye T, Bekele E, Geberemickeal G, Mebratu A, Ejigu AG, Nigatu T, Zeleke ED.
Int Health. 2024 Jun 3:ihae040.
doi: 10.1093/inthealth/ihae040. Online ahead of print.PMID: 38828522
-
Shedding of measles vaccine RNA in children after receiving measles, mumps and rubella vaccination.
Washam MC, Leber AL, Oyeniran SJ, Everhart K, Wang H.
J Clin Virol. 2024 Aug;173:105696.
doi: 10.1016/j.jcv.2024.105696. Epub 2024 May 24.PMID: 38823291
-
Seroprevalence of measles antibodies in the Italian general population in 2019-2020.
Grassi T, Bagordo F, Rota MC, Dettori M, Baldovin T, Napolitano F, Panico A, Massaro E, Marchi S, Furfaro G, Immordino P, Savio M, Gabutti G; Sero-epidemiological Study Group.
Vaccine. 2024 May 30:S0264-410X(24)00637-6.
doi: 10.1016/j.vaccine.2024.05.060. Online ahead of print.PMID: 38821819
-
Adapting response to a measles outbreak in a context of high vaccination and breakthrough cases: an example from Vaud, Switzerland, January to March 2024.
Cassini A, Cobuccio L, Glampedakis E, Cherpillod P, Crisinel PA, Pérez-Rodríguez FJ, Attinger M, Bachelin D, Tessemo MN, Maeusezahl M, Gardiol C, Boubaker K.
Euro Surveill. 2024 May;29(22):2400275.
doi: 10.2807/1560-7917.ES.2024.29.22.2400275.PMID: 38818746
-
The challenges and main recommendations to fight measles in India: A mini review.
Tabassum S, Hassan Hafeez M, Naeem A, Bibi A, Akilimali A, Sharma V.
New Microbes New Infect. 2024 May 15;60-61:101433.
doi: 10.1016/j.nmni.2024.101433. eCollection 2024 Aug-Oct.PMID: 38818247
-
How did the introduction of the measles-containing vaccine second dose (MCV2) affect measles vaccine uptake? - evidence from Nigeria.
Sato R.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2355036.
doi: 10.1080/21645515.2024.2355036. Epub 2024 May 23.PMID: 38783606
-
A measles outbreak in a school.
Bagcchi S.
Lancet Infect Dis. 2024 Jul;24(7):686.
doi: 10.1016/S1473-3099(24)00340-2. Epub 2024 May 20.PMID: 38782009
-
Predictors on parent's attitudes toward the measles-rubella (MR) vaccine in Jordan: An education program.
Al-Maghaireh D, Alsaqer K, Kawafha M, Jallad ST, Al Kofahi A.
Am J Infect Control. 2024 May 18:S0196-6553(24)00501-7.
doi: 10.1016/j.ajic.2024.05.008. Online ahead of print.PMID: 38763429
-
Second dose of measles-containing vaccine coverage and associated factors among children aged 24-36 months in Gondar city, Central Gondar, Northwest Ethiopia, 2023.
Adisu MA, Bogale WA, Alemu TG.
Front Public Health. 2024 May 2;12:1364865.
doi: 10.3389/fpubh.2024.1364865. eCollection 2024.PMID: 38756896
-
Real-Time Use of a Dynamic Model To Measure the Impact of Public Health Interventions on Measles Outbreak Size and Duration - Chicago, Illinois, 2024.
Masters NB, Holmdahl I, Miller PB, Kumar CK, Herzog CM, DeJonge PM, Gretsch S, Oliver SE, Patel M, Sugerman DE, Bruce BB, Borah BF, Olesen SW.
MMWR Morb Mortal Wkly Rep. 2024 May 16;73(19):430-434.
doi: 10.15585/mmwr.mm7319a2.PMID: 38753544
-
Measles Outbreak Associated with a Migrant Shelter - Chicago, Illinois, February-May 2024.
Gressick K, Nham A, Filardo TD, Anderson K, Black SR, Boss K, Chavez-Torres M, Daniel-Wayman S, Dejonge P, Faherty E, Funk M, Kerins J, Kim DY, Kittner A, Korban C, Pacilli M, Schultz A, Sloboda A, Zelencik S, Barnes A, Geltz JJ, Morgan J, Quinlan K, Reid H, Chatham-Stephens K, Lanzieri TM, Leung J, Lutz CS, Nyika P, Raines K, Ramachandran S, Rivera MI, Singleton J, Wang D, Rota PA, Sugerman D, Gretsch S, Borah BF; Chicago Department of Public Health Measles Response Team.
MMWR Morb Mortal Wkly Rep. 2024 May 16;73(19):424-429.
doi: 10.15585/mmwr.mm7319a1.PMID: 38753539
-
Measles Vaccine Coverage and Disease Outbreaks: A Systematic Review of the Early Impact of COVID-19 in Low and Lower-Middle Income Countries.
Packham A, Taylor AE, Karangwa MP, Sherry E, Muvunyi C, Green CA.
Int J Public Health. 2024 Apr 25;69:1606997.
doi: 10.3389/ijph.2024.1606997. eCollection 2024.PMID: 38725903
-
Exploring landscape of measles vaccination coverage: A step towards measles elimination goal in India.
Dhalaria P, Kumar P, Verma A, Priyadarshini P, Kumar Singh A, Tripathi B, Taneja G.
Vaccine. 2024 Jun 20;42(17):3637-3646.
doi: 10.1016/j.vaccine.2024.04.075. Epub 2024 May 3.PMID: 38704248
-
Measles and rubella vaccine microneedle patch: new hope to reach the unreached children.
Coulborn RM, Danet C, Alsalhani A.
Lancet. 2024 May 11;403(10439):1825-1827.
doi: 10.1016/S0140-6736(24)00749-9. Epub 2024 Apr 29.PMID: 38697172 No abstract available.
-
A measles and rubella vaccine microneedle patch in The Gambia: a phase 1/2, double-blind, double-dummy, randomised, active-controlled, age de-escalation trial.
Adigweme I, Yisa M, Ooko M, Akpalu E, Bruce A, Donkor S, Jarju LB, Danso B, Mendy A, Jeffries D, Segonds-Pichon A, Njie A, Crooke S, El-Badry E, Johnstone H, Royals M, Goodson JL, Prausnitz MR, McAllister DV, Rota PA, Henry S, Clarke E.
Lancet. 2024 May 11;403(10439):1879-1892.
doi: 10.1016/S0140-6736(24)00532-4. Epub 2024 Apr 29.PMID: 38697170
Clinical Trial.
Bibliography of citations on routine immunization, May-june 2024
-
Positive effects of health behaviors acquired during the COVID-19 pandemic process on the prevention of other infectious diseases.
Şimsek AÇ, Buzgan T, Baran Aksakal FN, Birinci Ş, Şirin H.
Turk J Med Sci. 2023 Oct 12;53(6):1756-1766.
doi: 10.55730/1300-0144.5745. eCollection 2023.PMID: 38813503
-
Persistence and heterogeneity of the effects of educating mothers to improve child immunisation uptake: Experimental evidence from Uttar Pradesh in India.
O’Neill S, Grieve R, Singh K, Dutt V, Powell-Jackson T.
J Health Econ. 2024 Jun;96:102899.
doi: 10.1016/j.jhealeco.2024.102899. Epub 2024 May 18.PMID: 38805881
Clinical Trial.
-
Information and vaccine hesitancy: The role of broadband Internet.
Amaral-Garcia S, Nardotto M, Propper C, Valletti T.
Health Econ. 2024 May 27.
doi: 10.1002/hec.4856. Online ahead of print.PMID: 38801742
-
Assessing the Impact of the COVID-19 Pandemic on Pregnant Women's Attitudes towards Childhood Vaccinations: A Cross-Sectional Study.
Arcaro P, Nachira L, Pattavina F, Campo E, Mancini R, Pascucci D, Damiani G, Carducci B, Spadea A, Lanzone A, Bruno S, Laurenti P.
Vaccines (Basel). 2024 Apr 29;12(5):473.
doi: 10.3390/vaccines12050473.PMID: 38793724
-
Trends and projections of age-appropriate vaccination coverage in 41 low- and middle- income countries in Asia and Sub-Saharan Africa, 2000-2030.
Islam MR, Rahman MM, Rahman MS, Abe SK, Akmatov MK, Hashizume M.
Front Public Health. 2024 May 9;12:1371258.
doi: 10.3389/fpubh.2024.1371258. eCollection 2024.PMID: 38784590
-
Immunity against measles, mumps, rubella, and varicella among homeless individuals in Germany - A nationwide multi-center cross-sectional study.
Graf W, Bertram F, Dost K, Brennecke A, Kowalski V, van Rüth V, Nörz DS, Wulff B, Ondruschka B, Püschel K, Pfefferle S, Lütgehetmann M, Heinrich F.
Front Public Health. 2024 May 9;12:1375151.
doi: 10.3389/fpubh.2024.1375151. eCollection 2024.PMID: 38784578
-
Childhood vaccination trends during 2019 to 2022 in Tanzania and the impact of the COVID-19 pandemic.
Sangeda RZ, James D, Mariki H, Mbwambo ME, Mwenesi ME, Nyaki H, Tinuga F, Manyanga DP.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2356342.
doi: 10.1080/21645515.2024.2356342. Epub 2024 May 23.PMID: 38780570
-
Vaccine Coverage at 36 Months and 7 Years by Parental Birth Country, Washington State.
Tasslimi A, Bell TR, Moore TP, DeBolt C, Ibrahim A, Matheson
J.Pediatrics. 2024 Jun 1;153(6):e2023064626.
doi: 10.1542/peds.2023-064626.PMID: 38774987
-
Effect of postpartum family planning intervention and associated factors during child immunization in Addis Ababa, Ethiopia.
Gelaw SG, Deyessa N, Kidane A, Evensen A, Teka A, Bokan B, Yesuf SA.
Pan Afr Med J. 2024 Mar 6;47:110.
doi: 10.11604/pamj.2024.47.110.34883. eCollection 2024.PMID: 38766567
Clinical Trial.
-
Shifting patterns and competing explanations for infectious disease priority in global health agenda setting arenas.
Smith SL, Parashar R, Nanda S, Shiffman J, Shroff ZC, Shawar YR, Hamunakwadi DL.
Health Policy Plan. 2024 May 16:czae035.
doi: 10.1093/heapol/czae035. Online ahead of print.PMID: 38753344
-
Effects of Iron Status on Adaptive Immunity and Vaccine Efficacy: A Review.
Stoffel NU, Drakesmith H.
Adv Nutr. 2024 Jun;15(6):100238.
doi: 10.1016/j.advnut.2024.100238. Epub 2024 May 8.PMID: 38729263
Measles and Rubella Citations, Third Quarter of 2024
-
Possible Paths to Measles Eradication: Conceptual Frameworks, Strategies, and Tactics.
Winter AK, Moss WJ.
Vaccines (Basel). 2024 Jul 22;12(7):814.
doi: 10.3390/vaccines12070814.PMID: 39066451
-
Optimal Timing Regularly Outperforms Higher Coverage in Preventative Measles Supplementary Immunization Campaigns.
Rosenfeld KA, Frey K, McCarthy KA.
Vaccines (Basel). 2024 Jul 22;12(7):820.
doi: 10.3390/vaccines12070820.PMID: 39066459
-
Measles: What goes around, comes around.
Moss WJ, Griffin DE.
J Infect Dis. 2024 Aug 8:jiae397.
doi: 10.1093/infdis/jiae397. Online ahead of print.PMID: 39115343
No abstract available.
-
Tracking Measles and Rubella Elimination Progress-World Health Organization African Region, 2022-2023.
Masresha BG, Wiysonge CS, Katsande R, O’Connor PM, Lebo E, Perry RT.
Vaccines (Basel). 2024 Aug 22;12(8):949.
doi: 10.3390/vaccines12080949.PMID: 39204072
-
The Problem with Delaying Measles Elimination.
Crowcroft NS, Minta AA, Bolotin S, Cernuschi T, Ariyarajah A, Antoni S, Mulders MN, Bose AS, O’Connor PM.
Vaccines (Basel). 2024 Jul 22;12(7):813.
doi: 10.3390/vaccines12070813.PMID: 39066457
-
What's going on with measles?
Moss WJ, Griffin DE.
J Virol. 2024 Aug 20;98(8):e0075824.
doi: 10.1128/jvi.00758-24. Epub 2024 Jul 23.PMID: 39041786
-
Exploring Important Attributes, the Potential Use Cases and Feasibility of Introduction of Measles and Rubella Microarray Patches (MR-MAPs): Insights from Nine Countries.
Hasso-Agopsowicz M, Spasenoska D, Jansen MPM, Masresha BG, Pastor D, Gebrekidan AH, Silalahi O, Woolford J, Kisakye A, Kahn AL, Giersing B.
Vaccines (Basel). 2024 Sep 23;12(9):1084.
doi: 10.3390/vaccines12091084.PMID: 39340114
-
Estimates of Potential Demand for Measles and Rubella Microarray Patches.
Kayembe LK, Fischer LS, Adhikari BB, Knapp JK, Khan EB, Greening BR, Papania M, Meltzer MI.
Vaccines (Basel). 2024 Sep 23;12(9):1083.
doi: 10.3390/vaccines12091083.PMID: 39340113
-
Progress with the Second Dose Measles Vaccine Introduction and Coverage in the WHO African Region.
Masresha BG, Shibeshi ME, Grant GB, Hatcher C, Wiysonge CS.
Vaccines (Basel). 2024 Sep 18;12(9):1069.
doi: 10.3390/vaccines12091069.PMID: 39340099
-
On the Path to Measles and Rubella Elimination Following Rubella-Containing Vaccine Introduction, 2000-2023, Namibia.
Masresha BG, Shibeshi ME, de Wee R, Shapumba N, Sayi T, Reef SE, Goodson JL.
Vaccines (Basel). 2024 Aug 23;12(9):957.
doi: 10.3390/vaccines12090957.PMID: 39339990
-
Measles and Rubella Elimination in the Western Pacific Region in 2013-2022: Lessons Learned from Progress and Achievements Made during Regional and Global Measles Resurgences.
Takashima Y, Aslam SK, Evans R, Mariano KM, Lee CW, Wang X, Grabovac V, Durrheim DN.
Vaccines (Basel). 2024 Jul 22;12(7):817.
doi: 10.3390/vaccines12070817.PMID: 39066454
-
Epidemiology of measles outbreaks, incidence and associated risk factors in Ethiopia from 2000 to 2023: a systematic review and meta-analysis.
Eshetu D, Tosisa W, Regassa BT, Hundie GB, Mulu A.
BMC Infect Dis. 2024 Sep 3;24(1):914.
doi: 10.1186/s12879-024-09828-6.PMID: 39227789
-
Factors Associated with Uptake of Routine Measles-Containing Vaccine Doses among Young Children, Oromia Regional State, Ethiopia, 2021.
Woyessa AB, Shah MP, Azmeraye BM, Pan J, Lisanwork L, Yimer G, Wang SH, Nuorti JP, Artama M, Matanock AM, An Q, Samuel P, Tolera B, Kenate B, Bekele A, Deti T, Wako G, Shiferaw A, Tefera YL, Kokebie MA, Anbessie TB, Wubie HT, Wallace A, Sugerman CE.
Vaccines (Basel). 2024 Jul 11;12(7):762.
doi: 10.3390/vaccines12070762.PMID: 39066400
-
Measles Outbreak Investigation in Aneded District, Northwest Ethiopia: A Case-Control Study.
Tariku MK, Belete AH, Worede DT, Tegegne BA, Bante SA, Misikir SW.
J Epidemiol Glob Health. 2024 Sep;14(3):1231-1241.
doi: 10.1007/s44197-024-00279-5. Epub 2024 Aug 1.PMID: 39088155
-
Measles second dose vaccine uptake and associated factors among under-five children in Jigjiga City, Somali Region, Eastern Ethiopia: a community-based cross-sectional study.
Ibrahim HA, Wariyo A, Asefa EM, Cheru A, Abebe Lonsako A, Dirirsa G.
Front Public Health. 2024 Jul 30;12:1395802.
doi: 10.3389/fpubh.2024.1395802. eCollection 2024.PMID: 39139669
-
Estimating immunization coverage at the district level: A case study of measles and diphtheria-pertussis-tetanus-Hib-HepB vaccines in Ethiopia.
Tesfaye L, Forzy T, Getnet F, Misganaw A, Woldekidan MA, Wolde AA, Warkaye S, Gelaw SK, Memirie ST, Berheto TM, Worku A, Sato R, Hendrix N, Tadesse MZ, Tefera YL, Hailu M, Verguet S.
PLOS Glob Public Health. 2024 Jul 25;4(7):e0003404.
doi: 10.1371/journal.pgph.0003404. eCollection 2024.PMID: 39052537
-
Qualitative Insights on Barriers to Receiving a Second Dose of Measles-Containing Vaccine (MCV2), Oromia Region of Ethiopia.
Solomon K, Aksnes BN, Woyessa AB, Geri C, Matanock AM, Shah MP, Samuel P, Tolera B, Kenate B, Bekele A, Deti T, Wako G, Shiferaw A, Tefera YL, Kokebie MA, Anbessie TB, Wubie HT, Wallace A, Sugerman CE, Kaba M.
Vaccines (Basel). 2024 Jun 22;12(7):702.
doi: 10.3390/vaccines12070702.PMID: 39066340
-
Long-term waning of vaccine-induced immunity to measles in England: a mathematical modelling study.
Robert A, Suffel AM, Kucharski AJ.
Lancet Public Health. 2024 Sep 19:S2468-2667(24)00181-6.
doi: 10.1016/S2468-2667(24)00181-6. Online ahead of print.PMID: 39342948
-
Factors influencing the first dose of measles vaccination uptake in 42 low- and middle-income countries.
Mahazabin M, Swarna SN, Naime J, Rahman A, Islam MA.
Public Health. 2024 Sep 27;237:85-93.
doi: 10.1016/j.puhe.2024.09.017. Online ahead of print.PMID: 39341152
-
Case Study: Contribution of Extended Sequencing and Phylogeographic Analysis in the Investigation of Measles Outbreaks in Tunisia in 2019.
Chouikha A, Arbi M, Souiai O, Touzi H, Meddeb Z, Ben Farhat E, Yahyaoui M, Ben Said A, Hamouda C, Triki H.
Vaccines (Basel). 2024 Sep 23;12(9):1085.
doi: 10.3390/vaccines12091085.PMID: 39340115
-
Low Rates of Immunity among Medical Students and Residents in the Era of the Resurgence of Measles.
Ferrari C, Somma G, Caputi V, Treglia M, Pallocci M, Cenko F, Buonomo E, Carestia M, Di Giampaolo L, Olesen OF, Coppeta L.
Pathogens. 2024 Sep 11;13(9):784.
doi: 10.3390/pathogens13090784.PMID: 39338975
-
Zero-dose children and the extended immunisation cascade: Understanding the path to full immunisation with six childhood vaccines in 43 countries.
Cata-Preta BO, Silva LAN, Costa FS, Santos TM, Mengistu T, Hogan DR, Victora CG, Barros AJD.
J Glob Health. 2024 Sep 27;14:04199.
doi: 10.7189/jogh.14.04199.PMID: 39325925
-
An urgent case for measles vaccination in Gaza.
Waldman R, Steinglass R, Nieburg P.
Lancet. 2024 Sep 20:S0140-6736(24)02076-2.
doi: 10.1016/S0140-6736(24)02076-2. Online ahead of print.PMID: 39312932 No abstract available.
-
The impact of household size on measles transmission: A long-term perspective.
Bidari S, Yang W.
Epidemics. 2024 Sep 6;49:100791.
doi: 10.1016/j.epidem.2024.100791. Online ahead of print.PMID: 39276494
-
The Effects of Vaccination Status and Age on Clinical Characteristics and Severity of Measles Cases in the United States in the Post-Elimination Era, 2001-2022.
Leung J, Munir NA, Mathis AD, Filardo TD, Rota PA, Sugerman DE, Sowers SB, Mercader S, Crooke SN, Gastañaduy PA.
Clin Infect Dis. 2024 Sep 13:ciae470.
doi: 10.1093/cid/ciae470. Online ahead of print.PMID: 39271123
-
Hospital-acquired infections and unvaccinated children due to chronic diseases: an investigation of the 2017-2019 measles outbreak in the northern region of Vietnam.
Tran DM, Ong T, Cao TV, Pham QT, Do H, Phan PH, Choisy M, Pham NTH.
BMC Infect Dis. 2024 Sep 10;24(1):948.
doi: 10.1186/s12879-024-09816-w.PMID: 39256671
-
Prediction of measles cases in US counties: A machine learning approach.
Kujawski SA, Ru B, Afanador NL, Conway JH, Baumgartner R, Pawaskar M.
Vaccine. 2024 Sep 7;42(26):126289.
doi: 10.1016/j.vaccine.2024.126289. Online ahead of print.PMID: 39244426
-
Measles in the Modern Era: A Review.
Azan L, Chuecos-Escalante S, Marte AP, Bhagi N.
Pediatr Ann. 2024 Sep;53(9):e345-e350.
doi: 10.3928/19382359-20240722-01. Epub 2024 Sep 1.PMID: 39240174
-
Contradictory mortality results in early 2-dose measles vaccine trials: interactions with oral polio vaccine may explain differences.
Nielsen S, Fisker AB, Sie A, Müller O, Nebie E, Becher H, van der Klis F, Biering-Sørensen S, Byberg S, Thysen SM, da Silva I, Rodrigues A, Martins C, Whittle HC, Aaby P, Benn CS.
Int J Infect Dis. 2024 Aug 30;148:107224.
doi: 10.1016/j.ijid.2024.107224. Online ahead of print.PMID: 39218141
-
Global Status Report for the Verification of Measles and Rubella Elimination, 2022.
O’Connor P, Masresha B, Pastor D, Musa N, Hagan J, Khanal S, Lee CW, Crowcroft N.
Vaccines (Basel). 2024 Aug 22;12(8):947.
doi: 10.3390/vaccines12080947.PMID: 39204070
-
The Global Measles and Rubella Laboratory Network Supports High-Quality Surveillance.
Rota PA, Evans R, Ben Mamou MC, Rey-Benito G, Sangal L, Dosseh A, Ghoniem A, Byabamazima CR, Demanou M, Anderson R, Kim G, Bankamp B, Beard RS, Crooke SN, Ramachandran S, Penedos A, Stambos V, Nicholson S, Featherstone D, Mulders MN.
Vaccines (Basel). 2024 Aug 22;12(8):946.
doi: 10.3390/vaccines12080946.PMID: 39204069
-
Strengthening of Vaccine-Preventable Disease (VPD) Surveillance to Enhance National Health Capacity and Security: Perspective from India.
Kumar A, Murugan R, Donkatti S, Sharma D, Kaundal N, Avagyan T, Kumar P, Bahl S, Khanal S, Bura V.
Vaccines (Basel). 2024 Aug 22;12(8):941.
doi: 10.3390/vaccines12080941.PMID: 39204063
-
Using Regular High-Quality Serosurveys to Identify and Close National Immunity Gaps-Measles and Rubella Elimination in Japan.
Sunagawa T, Kobayashi Y, Takashima Y, Kamiya H, Shimada T, Nakashima K, Arai S, Taniguchi K, Tanaka-Taya K, Okabe N.
Vaccines (Basel). 2024 Aug 22;12(8):939.
doi: 10.3390/vaccines12080939.PMID: 39204061
-
Measles Population Immunity Profiles: Updated Methods and Tools.
Li X, Goodson JL, Perry RT.
Vaccines (Basel). 2024 Aug 22;12(8):937.
doi: 10.3390/vaccines12080937.PMID: 39204060
-
Mapping the Implementation Determinants of Second Dose Measles Vaccination in the World Health Organization African Region: A Rapid Review.
Adamu AA, Jalo RI, Masresha BG, Ndwandwe D, Wiysonge CS.
Vaccines (Basel). 2024 Aug 8;12(8):896.
doi: 10.3390/vaccines12080896.PMID: 39204023
-
A Serological Survey of Measles and Rubella Antibodies among Different Age Groups in Eastern China.
Yan R, He H, Deng X, Zhou Y, Tang X, Zhu Y, Liang H, Chen Y, Yang M, Du Y, Chen C, Chen J, Yang S, Ridphe Group.
Vaccines (Basel). 2024 Jul 25;12(8):842.
doi: 10.3390/vaccines12080842.PMID: 39203968
-
Building Quality Control for Molecular Assays in the Global Measles and Rubella Laboratory Network.
Bankamp B, Anderson R, Hao L, Lopareva E, Chen MH, Kim G, Beard RS, Mori Y, Otsuki N, Ryo A, Rota PA.
Vaccines (Basel). 2024 Jul 23;12(8):824.
doi: 10.3390/vaccines12080824.PMID: 39203950
-
Use of Measles and Rubella Rapid Diagnostic Tests to Improve Case Detection and Targeting of Vaccinations.
Rachlin A, Hampton LM, Rota PA, Mulders MN, Papania M, Goodson JL, Krause LK, Hanson M, Osborn J, Kelly-Cirino C, Evans B, Sinha A, Warrener L, Featherstone D, Brown D.
Vaccines (Basel). 2024 Jul 23;12(8):823.
doi: 10.3390/vaccines12080823.PMID: 39203949
-
Adjusting mobile phone data to account for children's travel and the impact on measles dynamics in Zambia.
Kostandova N, Prosperi C, Mutembo S, Nakazwe C, Namukoko H, Nachinga B, Chongwe G, Chilumba I, Kabalo EN, Makungo K, Matakala KH, Musukwa G, Hamahuwa M, Mufwambi W, Matoba J, Mutale I, Simulundu E, Ndubani P, Hasan AZ, Truelove SA, Winter AK, Carcelen AC, Lau B, Moss WJ, Wesolowski A.
Am J Epidemiol. 2024 Aug 27:kwae304.
doi: 10.1093/aje/kwae304. Online ahead of print.PMID: 39191642
-
Onward transmission of measles virus among vaccinated cases in a large community outbreak in Auckland, New Zealand, 2019.
Evans I, Jury S, Morrison A, Best E, King V, Reynolds E.
Vaccine. 2024 Oct 3;42(23):126257.
doi: 10.1016/j.vaccine.2024.126257. Epub 2024 Aug 27.PMID: 39191179
-
Socio-demographic factors affecting the first and second dose of measles vaccination status among under-five children: Perspectives from South Asian countries.
Mahazabin M, Tabassum N, Syfullah SMK, Majumder UK, Islam MA.
Prev Med Rep. 2024 Jul 31;45:102839.
doi: 10.1016/j.pmedr.2024.102839. eCollection 2024 Sep.PMID: 39188972
-
Onward Virus Transmission after Measles Secondary Vaccination Failure.
Tranter I, Smoll N, Lau CL, Williams DL, Neucom D, Barnekow D, Dyda A.
Emerg Infect Dis. 2024 Sep;30(9):1747-1754.
doi: 10.3201/eid3009.240150.PMID: 39173667
-
Congenital rubella syndrome, a case series.
Medu O, Mahajan P, Hennink M, Stang L, Anderson M, Tan B, Oyenubi A, Plamondon M, Salvadori MI, Franklin K, Primeau C, Hiebert J, Minion J, Diener T.
Can Commun Dis Rep. 2024 Jul 24;50(7-8):274-281.
doi: 10.14745/ccdr.v50i78a05. eCollection 2024 Jul-Aug.PMID: 39170592
-
Measles immunity status in Iranian infants and children and outbreak concerns: Time for reconsidering the vaccination schedule?
Pourakbari B, Ashraf Talesh S, Mahmoudi S, Sotoudeh M, Hosseinpour Sadeghi R, Mamishi S.
Vaccine. 2024 Oct 3;42(23):126243.
doi: 10.1016/j.vaccine.2024.126243. Epub 2024 Aug 20.PMID: 39168077
-
Individual and contextual factors associated with measles infection in Malaysia: a multilevel analysis.
Daud MRHM, Yaacob NA, Arifin WN, Sani JAM, Ibadullah WAHW.Osong
Public Health Res Perspect. 2024 Aug 21.
doi: 10.24171/j.phrp.2024.0156. Online ahead of print.PMID: 39164020
-
Predicting the Airborne Transmission of Measles: Impact of Indoor Carbon Dioxide (CO2) Levels and Mitigation Strategies.
Iwamura N, Tsutsumi K.
Cureus. 2024 Jul 19;16(7):e64882.
doi: 10.7759/cureus.64882. eCollection 2024 Jul.PMID: 39156354
-
An Alarming Emergence of Measles in Europe: Gaps and Future Directions.
Keske Ş, Özsürekci Y, Ergönül Ö.
Balkan Med J. 2024 Sep 6;41(5):321-323.
doi: 10.4274/balkanmedj.galenos.2024.060824. Epub 2024 Aug 16.PMID: 39150366
-
Quantifying the long-term effects of measles infection-a retrospective cohort study.
Dor E, Fluss R, Israel A, Huppert A.
Clin Microbiol Infect. 2024 Aug 12:S1198-743X(24)00393-8.
doi: 10.1016/j.cmi.2024.08.007. Online ahead of print.PMID: 39142629
-
Impact of the COVID-19 Pandemic on Measles Vaccination Coverage and Estimated Catch-up Efforts for Serbia.
Burgess C, Lisul B, Pawaskar M, Petigara T, Murtagh J, Kanazir M, Loncarevic G, Carias C.
Pediatr Infect Dis J. 2024 Oct 1;43(10):1011-1017.
doi: 10.1097/INF.0000000000004487. Epub 2024 Sep 16.PMID: 39105529
-
The Resurgence of Measles: A Rash From the Past.
Gooch MD.
Adv Emerg Nurs J. 2024 Jul-Sep 01;46(3):217-227.
doi: 10.1097/TME.0000000000000521. Epub 2024 Aug 1.PMID: 39094081
-
Measles virus: Continued outbreaks while striving for eradication.
Sanchez DJ.
Virulence. 2024 Dec;15(1):2386022.
doi: 10.1080/21505594.2024.2386022. Epub 2024 Aug 2.PMID: 39092662
-
A historical syndemic? The impact of synergistic epidemics of measles and scarlet fever on life expectancy in Victoria, Australia (1860s-1870s).
Battles HT, Roberts PM.
Am J Biol Anthropol. 2024 Aug 1:e25008.
doi: 10.1002/ajpa.25008. Online ahead of print.PMID: 39087439
-
Increase in measles cases in a City hospital, Istanbul, Turkey.
Karabey M, Karabulut N, Alaçam S, Gündüz A, Caymaz C, Altuntaş Aydin Ö.Cent
Eur J Public Health. 2024 Jun;32(2):125-131.
doi: 10.21101/cejph.a7981.PMID: 39069316
-
Rising measles cases in Europe-a threat to children.
Das M.
Lancet Infect Dis. 2024 Aug;24(8):e489.
doi: 10.1016/S1473-3099(24)00449-3.PMID: 39067473 No abstract available.
-
Challenges for Sustaining Measles Elimination: Post-Verification Large-Scale Import-Related Measles Outbreaks in Mongolia and Cambodia, Resulting in the Loss of Measles Elimination Status.
Hagan J, Dashpagma O, Vichit O, Chham S, Demberelsuren S, Grabovac V, Hossain S, Iijima M, Lee CW, Purevdagva A, Mariano K, Evans R, Zhang Y, Takashima Y.
Vaccines (Basel). 2024 Jul 22;12(7):821.
doi: 10.3390/vaccines12070821.PMID: 39066458
-
"Anees Has Measles": Storytelling and Singing to Enhance MMR Vaccination in Child Care Centers Amid Religious Hesitancy.
Thongseiratch T, Khantee P, Jaroenmark N, Nuttapasit N, Thonglua N.
Vaccines (Basel). 2024 Jul 22;12(7):819.
doi: 10.3390/vaccines12070819.PMID: 39066456
-
A Cross-Sectional Study of Measles-Specific Antibody Levels in Australian Blood Donors-Implications for Measles Post-Elimination Countries.
Williamson KM, Faddy H, Nicholson S, Stambos V, Hoad V, Butler M, Housen T, Merritt T, Durrheim DN.
Vaccines (Basel). 2024 Jul 22;12(7):818.
doi: 10.3390/vaccines12070818.PMID: 39066455
-
Serosurveillance for Measles and Rubella.
Brady AM, El-Badry E, Padron-Regalado E, Escudero González NA, Joo DL, Rota PA, Crooke SN.
Vaccines (Basel). 2024 Jul 22;12(7):816.
doi: 10.3390/vaccines12070816.PMID: 39066453
-
Vaccination Week in the Americas: An Ongoing Initiative to Strengthen and Sustain Measles and Rubella Elimination in the Region.
Ropero AM, Kurtis H, Vulanovic L, Bravo-Alcántara P, Vera Antelo M, Ghiselli M.
Vaccines (Basel). 2024 Jul 22;12(7):812.
doi: 10.3390/vaccines12070812.PMID: 39066450
-
Global Update on Measles Molecular Epidemiology.
Bankamp B, Kim G, Hart D, Beck A, Ben Mamou M, Penedos A, Zhang Y, Evans R, Rota PA.
Vaccines (Basel). 2024 Jul 22;12(7):810.
doi: 10.3390/vaccines12070810.PMID: 39066448
-
Persistence of Antibodies against Measles, Mumps, and Rubella after the Two-Dose MMR Vaccination: A 7-Year Follow-Up Study.
Sarawanangkoor N, Wanlapakorn N, Srimuan D, Thatsanathorn T, Thongmee T, Poovorawan Y.
Vaccines (Basel). 2024 Jul 5;12(7):744.
doi: 10.3390/vaccines12070744.PMID: 39066382
-
Conflict and fragmented public health emergency management system in Tigray region of Northern Ethiopia: A double burden to accommodate resilient and advanced public health emergency management. A commentary review for policy-makers and a call to action.
Ajemu KF, Hadgu T, Gebreegziabher G, Ayele B, Gebretnsae H, Desta AA, Kahsay H.
Health Res Policy Syst. 2024 Sep 3;22(1):121.
doi: 10.1186/s12961-024-01176-w.PMID: 39227920
-
Successful Elimination of Endemic Rubella in the WHO European Region. Is It Proper to Remove the Recommendation for Preconceptional Immunization?
Cavaliere AF, Parasiliti M, Franco R, Gallitelli V, Perelli F, Spanò A, Pallone B, Serafini MG, Signore F, Eleftheriou G, Scambia G, Lanzone A, Vidiri A.Int
J Environ Res Public Health. 2024 Jul 22;21(7):957.
doi: 10.3390/ijerph21070957.PMID: 39063533
-
Appropriateness of Immunoglobulin M Testing for Measles, Mumps, and Rubella.
Filardo TD, Masters NB, Leung J, Baca S, Egwuogu H, Guevara OR, Raykin J, Sugerman DE.
Am J Prev Med. 2024 Jul 23:S0749-3797(24)00255-1.
doi: 10.1016/j.amepre.2024.07.014. Online ahead of print.PMID: 39053655
-
The reemergence of measles and the urgent need for uninterrupted genetic surveillance and vaccination.
Branda F, Giovanetti M, Romano C, Ciccozzi A, Sanna D, Ciccozzi M, Scarpa F.
Clin Microbiol Infect. 2024 Oct;30(10):1215-1218.
doi: 10.1016/j.cmi.2024.06.023. Epub 2024 Jul 22.PMID: 39048053 No abstract available.
-
Global resurgence of measles in the vaccination era and influencing factors.
Bidari S, Yang W.
Int J Infect Dis. 2024 Oct;147:107189.
doi: 10.1016/j.ijid.2024.107189. Epub 2024 Jul 23.PMID: 39048035
-
Measles Outbreak in Socioeconomically Diverse Sections: A Review.
Lanke R, Chimurkar V.
Cureus. 2024 Jun 21;16(6):e62879.
doi: 10.7759/cureus.62879. eCollection 2024 Jun.PMID: 39044898
-
Characteristics of patients admitted to the intensive care unit during the 2019 measles epidemic in Samoa: A retrospective clinical case series.
Vaai-Bartley CS, Bennett E, Arasi F, Kaspar A.
Trop Doct. 2024 Jul 23:494755241266673.
doi: 10.1177/00494755241266673. Online ahead of print.PMID: 39043033
-
Measles Back to the Future: Chicago's Current Measles Outbreak Demands the Creation of Federally Managed Isolation Housing Reminiscent of the Origin Story of the Vaccines for Children Program.
Fricchione MJ, Nguyen DC, Nash CB, Davis ES.
J Public Health Manag Pract. 2024 Sep-Oct 01;30(5):647-648.
doi: 10.1097/PHH.0000000000001992. Epub 2024 Jul 22.PMID: 39041760 No abstract available.
-
The Epidemiological Characteristics and Spatiotemporal Clustering of Measles - China, 2005-2022.
Liu Q, Li J, Liu S, Tang L, Wang X, Huang A, Xu X, Xiu Y, Yang H, Wen N, Rodewald L, Wang F, Yin Z.China
CDC Wkly. 2024 Jul 5;6(27):665-669.
doi: 10.46234/ccdcw2024.123.PMID: 39027631
-
On mathematical modelling of measles disease via collocation approach.
Ahmed S, Jahan S, Shah K, Abdeljawad T.
AIMS Public Health. 2024 May 6;11(2):628-653.
doi: 10.3934/publichealth.2024032. eCollection 2024.PMID: 39027389
Routine Immunization Citations, Third Quarter 2024
-
An Interrupted Time Series Analysis of the Impact of the COVID-19 Pandemic on Routine Vaccination Uptake in Kenya.
Ngigi M, Moride Y, Castilloux AM, Clemens SAC.
Vaccines (Basel). 2024 Jul 23;12(8):826.
doi: 10.3390/vaccines12080826.PMID: 39203951
-
Vaccine practices, literacy, and hesitancy among parents in the United Arab Emirates.
0Barqawi HJ, Samara KA, Kannas SM, Habbal O, AlSarraf NA, Dreezi MA, Abu-Gharbieh E.
PLoS One. 2024 Aug 27;19(8):e0307020.
doi: 10.1371/journal.pone.0307020. eCollection 2024.PMID: 39190761
-
Timeliness of Childhood Vaccinations Following Strengthening of the Second Year of Life (2YL) Immunization Platform and Introduction of Catch-Up Vaccination Policy in Ghana.
Muhoza P, Shah MP, Amponsa-Achiano K, Gao H, Quaye P, Opare W, Okae C, Aboyinga PN, Opare JKL, Ehlman DC, Wardle MT, Wallace AS.
Vaccines (Basel). 2024 Jun 27;12(7):716.
doi: 10.3390/vaccines12070716.PMID: 39066354
-
The Effect of Economic Growth on the Utilisation of Childhood Immunisation: New Evidence From 50 African Countries.
Immurana M, Abdul Rahman AM.
Health Serv Insights. 2024 Jul 24;17:11786329241261990.
doi: 10.1177/11786329241261990. eCollection 2024.PMID: 39049962
-
Navigating Pakistan's immunization landscape: Progress and pitfalls.
Ashraf MF, Daim SUR, Fayyaz H, Ashraf MA, Ashraf M.
IJID Reg. 2024 Jun 3;12:100382.
doi: 10.1016/j.ijregi.2024.100382. eCollection 2024 Sep.PMID: 39036066
-
Evaluating the impact of COVID-19 on routine childhood immunizations coverage in Zambia.
Mwangilwa K, Chileshe C, Simwanza J, Chipoya M, Simwaba D, Kapata N, Mazaba ML, Mbewe N, Muzala K, Sinyange N, Fwemba I, Chilengi R.
PLOS Glob Public Health. 2024 Jul 30;4(7):e0003407.
doi: 10.1371/journal.pgph.0003407. eCollection 2024.PMID: 39078841
-
Human health implications of emerging diseases and the current situation in India's vaccine industry.
Behera JK, Mishra P, Jena AK, Behera B, Bhattacharya M.
Sci One Health. 2023 Oct 29;2:100046.
doi: 10.1016/j.soh.2023.100046. eCollection 2023.PMID: 39077045
-
Factors contributing to immunization coverage among children less than 5 years in Nadowli-Kaleo District of Upper West Region, Ghana.
Kuuyi A, Kogi R.
PLOS Glob Public Health. 2024 Aug 1;4(8):e0002881.
doi: 10.1371/journal.pgph.0002881. eCollection 2024.PMID: 39088462
-
Strengthening life-course immunisation in migrant populations: access, equity, and inclusion.Knights F, Carter J, Deal A, Crawshaw A, Bouaddi O, Sanchez-Clemente N, Seedat F, Vanderslott S, Eagan R, Holt DE, Ciftci Y, Orcutt M, Seale H, Severoni S, Hargreaves S. Lancet Reg Health Eur. 2024 May 28;41:100806. doi: 10.1016/j.lanepe.2023.100806. eCollection 2024 Jun.PMID: 39119098 Free PMC article.
Knights F, Carter J, Deal A, Crawshaw A, Bouaddi O, Sanchez-Clemente N, Seedat F, Vanderslott S, Eagan R, Holt DE, Ciftci Y, Orcutt M, Seale H, Severoni S, Hargreaves S.
Lancet Reg Health Eur. 2024 May 28;41:100806.
doi: 10.1016/j.lanepe.2023.100806. eCollection 2024 Jun.PMID: 39119098
-
Health and Economic Benefits of Routine Childhood Immunizations in the Era of the Vaccines for Children Program - United States, 1994-2023.
Zhou F, Jatlaoui TC, Leidner AJ, Carter RJ, Dong X, Santoli JM, Stokley S, Daskalakis DC, Peacock G.
MMWR Morb Mortal Wkly Rep. 2024 Aug 8;73(31):682-685.
doi: 10.15585/mmwr.mm7331a2.PMID: 39116024
-
Strengthening life-course immunisation in migrant populations: access, equity, and inclusion.
Knights F, Carter J, Deal A, Crawshaw A, Bouaddi O, Sanchez-Clemente N, Seedat F, Vanderslott S, Eagan R, Holt DE, Ciftci Y, Orcutt M, Seale H, Severoni S, Hargreaves S.
Lancet Reg Health Eur. 2024 May 28;41:100806.
doi: 10.1016/j.lanepe.2023.100806. eCollection 2024 Jun.PMID: 39119098
-
Health and Economic Benefits of Routine Childhood Immunizations in the Era of the Vaccines for Children Program - United States, 1994-2023.
Zhou F, Jatlaoui TC, Leidner AJ, Carter RJ, Dong X, Santoli JM, Stokley S, Daskalakis DC, Peacock G.
MMWR Morb Mortal Wkly Rep. 2024 Aug 8;73(31):682-685.
doi: 10.15585/mmwr.mm7331a2.PMID: 39116024
-
Strengthening life-course immunisation in migrant populations: access, equity, and inclusion.
Knights F, Carter J, Deal A, Crawshaw A, Bouaddi O, Sanchez-Clemente N, Seedat F, Vanderslott S, Eagan R, Holt DE, Ciftci Y, Orcutt M, Seale H, Severoni S, Hargreaves S.
Lancet Reg Health Eur. 2024 May 28;41:100806.
doi: 10.1016/j.lanepe.2023.100806. eCollection 2024 Jun.PMID: 39119098
-
Health and Economic Benefits of Routine Childhood Immunizations in the Era of the Vaccines for Children Program - United States, 1994-2023.
Zhou F, Jatlaoui TC, Leidner AJ, Carter RJ, Dong X, Santoli JM, Stokley S, Daskalakis DC, Peacock G.
MMWR Morb Mortal Wkly Rep. 2024 Aug 8;73(31):682-685.
doi: 10.15585/mmwr.mm7331a2.PMID: 39116024
-
Vital Signs: Trends and Disparities in Childhood Vaccination Coverage by Vaccines for Children Program Eligibility - National Immunization Survey-Child, United States, 2012-2022.
Valier MR, Yankey D, Elam-Evans LD, Chen M, Hill HA, Mu Y, Pingali C, Gomez JA, Arthur BC, Surtees T, Graitcer SB, Dowling NF, Stokley S, Peacock G, Singleton JA.
MMWR Morb Mortal Wkly Rep. 2024 Aug 22;73(33):722-730.
doi: 10.15585/mmwr.mm7333e1.PMID: 39173180
-
Discovering vaccines: the trial tale.
Vinusha V, Girish C.Naunyn Schmiedebergs
Arch Pharmacol. 2024 Aug 23.
doi: 10.1007/s00210-024-03368-1. Online ahead of print.PMID: 39177789 Review.
-
Possible counter-intuitive impact of local vaccine mandates for vaccine-preventable infectious diseases.
Donà M, Trapman P.
Math Biosci Eng. 2024 Jul 8;21(7):6521-6538.
doi: 10.3934/mbe.2024284.PMID: 39176406
-
SMS-Based Active Surveillance of Adverse Events following Immunization in Children: The VigiVax Study.
Gonella LA, Moretti F, Capuano A, De Sarro C, Ferrara L, Geninatti E, Guarnieri G, Hysolakoj X, Lalli M, Leoni O, Mangano AMP, Marani Toro P, Mecchia V, Merlano MC, Palleria C, Potenza AM, Rossi P, Rossi M, Sanità F, Sapigni E, Scavone C, Sommaro C, Tuccori M, Zanoni G, Moretti U, VigiVax Working Group.
Vaccines (Basel). 2024 Sep 20;12(9):1076.
doi: 10.3390/vaccines12091076.PMID: 39340106
-
Increasing immunization coverage, Solomon Islands, 2022.
Angessa R, Siliota R, Anga J, Kofela T, Tanevska S, Bainvalu N, McNeil P, Sobel HL.
Bull World Health Organ. 2024 Oct 1;102(10):736-741.
doi: 10.2471/BLT.24.291084. Epub 2024 Sep 2.PMID: 39318888
-
Vaccine Completion and Timeliness Among Children in the Military Health System: 2010-2019.
Romano CJ, Burrell M, Bukowinski AT, Hall C, Gumbs GR, Conlin AMS, Ramchandar N.
Pediatrics. 2024 Oct 1;154(4):e2023064965.
doi: 10.1542/peds.2023-064965.PMID: 39295511
-
Minimizing Vaccine Wastage in Nigeria: A National Assessment of Vaccine Wastage Rates and Potential Determinants.
Lambo K, Prescott M, Wiwa O, Adebowale J, Daradara K.
Vaccines (Basel). 2024 Aug 8;12(8):900.
doi: 10.3390/vaccines12080900.PMID: 39204026
Partnership Alliance
The mark 'CDC' is owned by the US Dept. of Health and Human Services and is used with permission. Use of this logo is not an endorsement by HHS or CDC of any particular product, service, or enterprise. CDC's logo and work with the Partnership is not connected to any fundraising aspect of the organization.
Follow Us
Prelude Version 2.3.2